Kathryn Flanagan

Kathryn Flanagan is an experienced professional in clinical trial management with a focus on cardiovascular studies. Currently serving as an eTMF Manager at KalVista Pharmaceuticals, Inc. since November 2021, Kathryn previously held the position of Clinical Trial Associate at The Medicines Company from June 2018 and has also worked as a Sr. Clinical Trial Assistant at DOCS. Notable experiences include maintaining electronic and paper trial master files, updating key study documents, collaborating cross-functionally with various study team departments, and assisting in the development of a new Clinical Trial Management System using Power Apps. Kathryn holds a Bachelor of Science degree in Public Health from Montclair State University, completed in 2018, and has a foundational background in public health initiatives through internships with The Alcohol and Drug Abuse Prevention Team and The Medicines Company.